Methods of screening for cell proliferation or neoplastic disorders

Details for Australian Patent Application No. 2005250494 (hide)

Owner The Johns Hopkins University National Institute of Health

Inventors Feinberg, Andrew P.; Iacobuzio-Donahue, Christine A.; Longo, Dan L.; Ko, Minoru

Agent Freehills

Pub. Number AU-B-2005250494

PCT Pub. Number WO2005/118878

Priority 60/656,470 24.02.05 US; 60/646,296 24.01.05 US; 60/576,566 03.06.04 US

Filing date 3 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 23 December 2010

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/118878 Priority application(s): WO2005/118878

23 December 2010 Application Accepted

  Published as AU-B-2005250494

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250495-Identification of tumors

2005250487-Intermediates for the preparation of analogs of halichondrin B